Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.78898892222354e-46,35.15439202148063,3656.183756831832,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.6137607350560627e-43,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.808302473257899e-28,16.690503003003002,1046.7130878895075,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",1.1180982261021455e-25,0,0,51
3,Oxidative phosphorylation WP623,1.0561944654506414e-16,15.715571557155716,578.1238459498966,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.3554495639949899e-14,0,0,30
4,Nonalcoholic fatty liver disease WP4396,8.09250300638419e-14,5.668818542428249,170.88797044011548,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'PPARA']",7.789034143644782e-12,0,0,42
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.1577977568663944e-08,7.593761334784186,138.76961744537527,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",8.915042727871237e-07,0,0,20
6,Mitochondrial CIV Assembly WP4922,3.705702296074226e-08,10.092692909594318,172.6941300700658,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'SMIM20', 'COX20']",2.377825639980962e-06,0,0,16
7,Mitochondrial complex III assembly WP4921,0.0048804114714070465,5.619506966773848,29.909970503513986,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.26842263092738755,0,0,6
8,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.012356680325546763,16.82051282051282,73.90190615352272,"['GSTP1', 'EPHX2', 'COX5A']",0.48380621166419796,0,0,3
9,Glutathione metabolism WP100,0.012356680325546763,16.82051282051282,73.90190615352272,"['GPX4', 'IDH1', 'GSS']",0.48380621166419796,0,0,3
10,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.012566395108160986,7.4809269162210335,32.74199040097424,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.48380621166419796,0,0,4
11,Synaptic Vesicle Pathway WP2267,0.016069832107668058,2.9983530254206947,12.385631298940291,"['UNC13B', 'UNC13C', 'SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1']",0.562444123768382,0,0,8
12,Transcription co-factors SKI and SKIL protein partners WP4533,0.027415045851020368,8.408653846153847,30.243096671090004,"['LATS1', 'MERTK', 'STK3']",0.8795660543869035,0,0,3
13,Base Excision Repair WP4752,0.033343285712322854,3.0622624963460976,10.414445017092014,"['POLE4', 'PCNA', 'NEIL2', 'MPG', 'TDG', 'POLD2']",0.9667110810679196,0,0,6
14,Hippo-Yap signaling pathway WP4537,0.03515313022065162,4.486844919786097,15.02214349566272,"['LATS1', 'NF2', 'TNIK', 'STK3']",0.9667110810679196,0,0,4
15,Cellular Proteostasis WP4918,0.04871305695392138,5.604700854700854,16.93633086055841,"['VBP1', 'PFDN4', 'PFDN6']",0.9991746621801322,0,0,3
16,Translation Factors WP107,0.06157413312404072,2.139225615058053,5.96312009637002,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.9991746621801322,0,0,8
17,Cytosine methylation WP3585,0.062047791596031014,11.2017075773746,31.13907082681061,"['IDH1', 'TDG']",0.9991746621801322,0,0,2
18,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.062047791596031014,11.2017075773746,31.13907082681061,"['EPHX2', 'PPARA']",0.9991746621801322,0,0,2
19,Metastatic brain tumor WP2249,0.062047791596031014,11.2017075773746,31.13907082681061,"['CDK6', 'E2F3']",0.9991746621801322,0,0,2
20,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.07178789255441459,3.2036669213139803,8.438585037854569,"['MDH2', 'IDH3G', 'OGDH', 'IDH3A']",0.9991746621801322,0,0,4
21,Glycolysis in senescence WP5049,0.07582308590241378,4.202724358974359,10.840307453307119,"['LDHA', 'ALDOC', 'HK1']",0.9991746621801322,0,0,3
22,Nanomaterial induced apoptosis WP2507,0.07582308590241378,4.202724358974359,10.840307453307119,"['ENDOG', 'CASP6', 'CYCS']",0.9991746621801322,0,0,3
23,Type II diabetes mellitus WP1584,0.07582308590241378,4.202724358974359,10.840307453307119,"['SURF1', 'PRKCD', 'PHKA2']",0.9991746621801322,0,0,3
24,DNA IR-double strand breaks and cellular response via ATM WP3959,0.10402595464987228,2.1032958199356915,4.759999997804348,"['LATS1', 'ATF2', 'DCLRE1C', 'PCNA', 'TRIM28', 'STK3']",0.9991746621801322,0,0,6
25,DNA Mismatch Repair WP531,0.10802969585633529,3.3615384615384616,7.480596684190997,"['POLE4', 'PCNA', 'POLD2']",0.9991746621801322,0,0,3
26,DNA Repair Pathways Full Network WP4946,0.11954512339614894,1.6510479326283796,3.5069271456723756,"['POLE4', 'DCLRE1C', 'NEIL2', 'PCNA', 'CENPX', 'MPG', 'FANCL', 'TDG', 'POLD2', 'GTF2H5']",0.9991746621801322,0,0,10
27,Oxidative Damage WP3941,0.12171924812061613,2.4907902554961376,5.245699254635265,"['PCNA', 'BAD', 'TRAF3', 'CYCS']",0.9991746621801322,0,0,4
28,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.1509591730954227,2.241283422459893,4.237697342189766,"['LATS1', 'ITGB5', 'NF2', 'STK3']",0.9991746621801322,0,0,4
29,15q11.2 copy number variation syndrome WP4940,0.15174505625147078,inf,inf,['TUBGCP4'],0.9991746621801322,0,0,1
30,Glucuronidation WP698,0.15174505625147078,inf,inf,['HK1'],0.9991746621801322,0,0,1
31,Apoptosis Modulation by HSP70 WP384,0.16795492476282406,3.7324795446460333,6.658966114827301,"['CASP6', 'CYCS']",0.9991746621801322,0,0,2
32,Serotonin and anxiety-related events WP3944,0.16795492476282406,3.7324795446460333,6.658966114827301,"['CRH', 'HTR2C']",0.9991746621801322,0,0,2
33,Ferroptosis WP4313,0.1758674603139706,1.8679514632405425,3.2465456583009162,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2', 'ATG7']",0.9991746621801322,0,0,5
34,Parkinson's disease pathway WP2371,0.18253781656753626,2.037141468157511,3.4647659582548394,"['CASP6', 'CYCS', 'PARK7', 'UBE2J1']",0.9991746621801322,0,0,4
35,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.18422048984057943,2.40018315018315,4.0602024394918965,"['IDH1', 'OGDH', 'IDH3A']",0.9991746621801322,0,0,3
36,Type II interferon signaling (IFNG) WP619,0.18422048984057943,2.40018315018315,4.0602024394918965,"['PRKCD', 'IRF2', 'HLA-B']",0.9991746621801322,0,0,3
37,Amino Acid metabolism WP3925,0.20237657627714772,1.569442060085837,2.507379993852639,"['LARS2', 'LDHA', 'MDH2', 'IDH1', 'GSS', 'ODC1', 'OGDH']",0.9991746621801322,0,0,7
38,One-carbon metabolism and related pathways WP3940,0.21603226032252396,1.8670231729055258,2.8608910053202026,"['GPX4', 'CHKA', 'GSS', 'ETNK1']",0.9991746621801322,0,0,4
39,7q11.23 copy number variation syndrome WP4932,0.2186037489331786,1.4017761033369214,2.1313929305558648,"['ATP5F1A', 'PCNA', 'ATP5F1B', 'ATP5MC2', 'OGDH', 'ATP5PO', 'SQSTM1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.9991746621801322,0,0,10
40,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.2275758703876902,2.7988260405549625,4.143022701115197,"['MAP1LC3A', 'ATG7']",0.9991746621801322,0,0,2
41,Nanoparticle triggered autophagic cell death WP2509,0.2275758703876902,2.7988260405549625,4.143022701115197,"['MAP1LC3A', 'ATG7']",0.9991746621801322,0,0,2
42,Thiamine metabolic pathways WP4297,0.2275758703876902,2.7988260405549625,4.143022701115197,"['BCKDK', 'OGDH']",0.9991746621801322,0,0,2
43,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.23325894210608772,1.6475626653230886,2.3982022706960637,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9991746621801322,0,0,5
44,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.23325894210608772,1.6475626653230886,2.3982022706960637,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'PIN1']",0.9991746621801322,0,0,5
45,Proteasome Degradation WP183,0.24982104149258663,1.452630742330313,2.014814021754831,"['PSMB6', 'PSMC5', 'PSMB5', 'PSMB3', 'PSMC1', 'HLA-B', 'PSMB10']",0.9991746621801322,0,0,7
46,Energy Metabolism WP1541,0.25101115713125355,1.7230769230769232,2.3817366722001037,"['ATF2', 'PPRC1', 'PPARA', 'PPARGC1B']",0.9991746621801322,0,0,4
47,Wnt Signaling Pathway WP363,0.25101115713125355,1.7230769230769232,2.3817366722001037,"['PRKCG', 'CDK6', 'DVL3', 'ROR2']",0.9991746621801322,0,0,4
48,SARS-CoV-2 mitochondrial interactions WP5038,0.2701057593300618,1.8660968660968662,2.442611995794348,"['NDUFB9', 'IRF3', 'TRAF3']",0.9991746621801322,0,0,3
49,White fat cell differentiation WP4149,0.2701057593300618,1.8660968660968662,2.442611995794348,"['IRF3', 'DDIT3', 'NR2F2']",0.9991746621801322,0,0,3
50,Apoptosis WP254,0.27077704537461866,1.461205088773941,1.9090052806499194,"['IRF3', 'CASP6', 'TRAF3', 'BAD', 'IRF2', 'CYCS']",0.9991746621801322,0,0,6
51,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.2804844094303352,5.594882729211087,7.1124227020721165,['TRAF3'],0.9991746621801322,0,0,1
52,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.2804844094303352,5.594882729211087,7.1124227020721165,['VIP'],0.9991746621801322,0,0,1
53,EV release from cardiac cells and their functional effects WP3297,0.2804844094303352,5.594882729211087,7.1124227020721165,['ERBB4'],0.9991746621801322,0,0,1
54,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.2804844094303352,5.594882729211087,7.1124227020721165,['GSS'],0.9991746621801322,0,0,1
55,Gastric acid production WP2596,0.2804844094303352,5.594882729211087,7.1124227020721165,['VIP'],0.9991746621801322,0,0,1
56,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.2804844094303352,5.594882729211087,7.1124227020721165,['ELOB'],0.9991746621801322,0,0,1
57,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.2804844094303352,5.594882729211087,7.1124227020721165,['BLVRB'],0.9991746621801322,0,0,1
58,let-7 inhibition of ES cell reprogramming WP3299,0.2804844094303352,5.594882729211087,7.1124227020721165,['SOX2'],0.9991746621801322,0,0,1
59,"Phase I biotransformations, non P450 WP136",0.2804844094303352,5.594882729211087,7.1124227020721165,['CES2'],0.9991746621801322,0,0,1
60,Small Ligand GPCRs WP247,0.2804844094303352,5.594882729211087,7.1124227020721165,['LPAR1'],0.9991746621801322,0,0,1
61,Valproic acid pathway WP3871,0.2804844094303352,5.594882729211087,7.1124227020721165,['IVD'],0.9991746621801322,0,0,1
62,Cytosolic DNA-sensing pathway WP4655,0.2870500236198199,1.599694423223835,1.9965766581325362,"['CYLD', 'IRF3', 'POLR3GL', 'POLR2K']",0.9991746621801322,0,0,4
63,Cell Differentiation - Index expanded WP2023,0.28827698296071225,2.23863393810032,2.7844879192120473,"['SOX2', 'LEFTY1']",0.9991746621801322,0,0,2
64,Kennedy pathway from sphingolipids WP3933,0.28827698296071225,2.23863393810032,2.7844879192120473,"['CHKA', 'ETNK1']",0.9991746621801322,0,0,2
65,Mitochondrial Gene Expression WP391,0.28827698296071225,2.23863393810032,2.7844879192120473,"['PPRC1', 'PPARGC1B']",0.9991746621801322,0,0,2
66,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.28827698296071225,2.23863393810032,2.7844879192120473,"['MDH2', 'NAMPT']",0.9991746621801322,0,0,2
67,SARS coronavirus and innate immunity WP4912,0.28827698296071225,2.23863393810032,2.7844879192120473,"['IRF3', 'TRAF3']",0.9991746621801322,0,0,2
68,Selenium Micronutrient Network WP15,0.29500610498839236,1.473571509072467,1.7988760177894343,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOH']",0.9991746621801322,0,0,5
69,Metapathway biotransformation Phase I and II WP702,0.30027672825601387,1.318000884564352,1.5856220211864325,"['CYP4Z1', 'GPX4', 'GSTO1', 'EPHX2', 'GSTP1', 'GSS', 'NDST3', 'KCNAB3']",0.9991746621801322,0,0,8
70,Pyrimidine metabolism WP4022,0.30027672825601387,1.318000884564352,1.5856220211864325,"['POLE4', 'POLR3GL', 'POLR1B', 'POLD2', 'ENPP1', 'NME3', 'POLR2I', 'POLR2K']",0.9991746621801322,0,0,8
71,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.3146217075158605,1.6791666666666667,1.9417619542464541,"['IFITM3', 'ATF2', 'DDIT3']",0.9991746621801322,0,0,3
72,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.3483594010673766,1.8651725364638918,1.9668628071419174,"['FGF1', 'GTPBP4']",0.9991746621801322,0,0,2
73,Hematopoietic Stem Cell Differentiation WP2849,0.3483594010673766,1.8651725364638918,1.9668628071419174,"['PIM1', 'ACVR1B']",0.9991746621801322,0,0,2
74,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3483594010673766,1.8651725364638918,1.9668628071419174,"['SESN3', 'SHISA5']",0.9991746621801322,0,0,2
75,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.3483594010673766,1.8651725364638918,1.9668628071419174,"['LATS1', 'STK3']",0.9991746621801322,0,0,2
76,Serotonin and anxiety WP3947,0.3483594010673766,1.8651725364638918,1.9668628071419174,"['CRH', 'HTR2C']",0.9991746621801322,0,0,2
77,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3483594010673766,1.8651725364638918,1.9668628071419174,"['IRF3', 'TRAF3']",0.9991746621801322,0,0,2
78,Zinc homeostasis WP3529,0.3483594010673766,1.8651725364638918,1.9668628071419174,"['SLC30A3', 'SLC39A11']",0.9991746621801322,0,0,2
79,MECP2 and Associated Rett Syndrome WP3584,0.356043172135829,1.291862478357655,1.3341106257343642,"['RBFOX1', 'BCL6', 'SST', 'RPS6', 'CAMK2A', 'MBP']",0.9991746621801322,0,0,6
80,Non-small cell lung cancer WP4255,0.35903712625520956,1.3327215254410114,1.3651459472573781,"['PRKCG', 'CDK6', 'BAD', 'CYCS', 'E2F3']",0.9991746621801322,0,0,5
81,DNA Replication WP466,0.35925693461977454,1.5262237762237763,1.5624219140985174,"['PCNA', 'POLD2', 'UBA52']",0.9991746621801322,0,0,3
82,Modulators of TCR signaling and T cell activation WP5072,0.36071197986736325,1.3991978609625668,1.426727748806415,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9991746621801322,0,0,4
83,Nucleotide Excision Repair WP4753,0.36071197986736325,1.3991978609625668,1.426727748806415,"['POLE4', 'PCNA', 'POLD2', 'GTF2H5']",0.9991746621801322,0,0,4
84,Cell Differentiation - Index WP2029,0.38970267989516855,2.796908315565032,2.635725817226917,['LEFTY1'],0.9991746621801322,0,0,1
85,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.38970267989516855,2.796908315565032,2.635725817226917,['PPARA'],0.9991746621801322,0,0,1
86,Homologous recombination WP186,0.38970267989516855,2.796908315565032,2.635725817226917,['POLD2'],0.9991746621801322,0,0,1
87,Irinotecan pathway WP229,0.38970267989516855,2.796908315565032,2.635725817226917,['CES2'],0.9991746621801322,0,0,1
88,NAD+ metabolism WP3644,0.38970267989516855,2.796908315565032,2.635725817226917,['NAMPT'],0.9991746621801322,0,0,1
89,Non-homologous end joining WP438,0.38970267989516855,2.796908315565032,2.635725817226917,['DCLRE1C'],0.9991746621801322,0,0,1
90,CAMKK2  Pathway WP4874,0.40343670079819627,1.3987713675213675,1.2697146769558956,"['FIS1', 'MAP1LC3A', 'SQSTM1']",0.9991746621801322,0,0,3
91,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.40343670079819627,1.3987713675213675,1.2697146769558956,"['DEPTOR', 'MAP1LC3A', 'ATG7']",0.9991746621801322,0,0,3
92,Prader-Willi and Angelman Syndrome WP3998,0.40343670079819627,1.3987713675213675,1.2697146769558956,"['CDK6', 'HTR2C', 'NGF']",0.9991746621801322,0,0,3
93,Regulation of toll-like receptor signaling pathway WP1449,0.405464254822147,1.1871504747041228,1.071667515846602,"['OTUD5', 'CYLD', 'CUEDC2', 'IRF3', 'TRAF3', 'SQSTM1', 'RNF41']",0.9991746621801322,0,0,7
94,Computational Model of Aerobic Glycolysis WP4629,0.406614069733667,1.5984143924378715,1.438398366395098,"['LDHA', 'HK1']",0.9991746621801322,0,0,2
95,Cori Cycle WP1946,0.406614069733667,1.5984143924378715,1.438398366395098,"['LDHA', 'HK1']",0.9991746621801322,0,0,2
96,Fas ligand pathway and stress induction of heat shock proteins WP314,0.406614069733667,1.5984143924378715,1.438398366395098,"['CASP6', 'CYCS']",0.9991746621801322,0,0,2
97,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.406614069733667,1.5984143924378715,1.438398366395098,"['B4GALT2', 'B3GALT2']",0.9991746621801322,0,0,2
98,MTHFR deficiency WP4288,0.406614069733667,1.5984143924378715,1.438398366395098,"['CHKA', 'CYCS']",0.9991746621801322,0,0,2
99,Neural Crest Cell Migration during Development WP4564,0.406614069733667,1.5984143924378715,1.438398366395098,"['CDH11', 'EPHB3']",0.9991746621801322,0,0,2
100,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.406614069733667,1.5984143924378715,1.438398366395098,"['OMG', 'MBP']",0.9991746621801322,0,0,2
101,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.423430719174162,1.2163671911367657,1.0453038404894532,"['PFKFB2', 'ATF2', 'BAD', 'RPS6', 'ZNF516']",0.9991746621801322,0,0,5
102,B Cell Receptor Signaling Pathway WP23,0.442801895756632,1.157556270096463,0.9429833018356937,"['ATF2', 'BCL6', 'PRKCD', 'CAMK2A', 'PIP5K1A', 'E2F3']",0.9991746621801322,0,0,6
103,Glycogen Synthesis and Degradation WP500,0.4466838627363866,1.2909270216962525,1.04036347870678,"['PHKG1', 'PHKA2', 'HK1']",0.9991746621801322,0,0,3
104,Histone Modifications WP2369,0.4466838627363866,1.2909270216962525,1.04036347870678,"['SET', 'SETDB2', 'KMT5A']",0.9991746621801322,0,0,3
105,Autophagy WP4923,0.46221244104229714,1.3983457844183564,1.0791463214008874,"['DEPTOR', 'ATG7']",0.9991746621801322,0,0,2
106,Cell migration and invasion through p75NTR WP4561,0.46221244104229714,1.3983457844183564,1.0791463214008874,"['EFNB2', 'CDH11']",0.9991746621801322,0,0,2
107,Globo Sphingolipid Metabolism WP1424,0.46221244104229714,1.3983457844183564,1.0791463214008874,"['ST6GAL1', 'ST6GAL2']",0.9991746621801322,0,0,2
108,miRNA targets in ECM and membrane receptors WP2911,0.46221244104229714,1.3983457844183564,1.0791463214008874,"['ITGB5', 'COL5A1']",0.9991746621801322,0,0,2
109,Neural Crest Cell Migration in Cancer WP4565,0.46221244104229714,1.3983457844183564,1.0791463214008874,"['CDH11', 'EPHB3']",0.9991746621801322,0,0,2
110,Toll-like Receptor Signaling related to MyD88 WP3858,0.46221244104229714,1.3983457844183564,1.0791463214008874,"['IRF3', 'TRAF3']",0.9991746621801322,0,0,2
111,Eukaryotic Transcription Initiation WP405,0.4700115042674303,1.177596397410639,0.8890830513412208,"['TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.9991746621801322,0,0,4
112,Glycolysis and Gluconeogenesis WP534,0.4700115042674303,1.177596397410639,0.8890830513412208,"['LDHA', 'MDH2', 'ALDOC', 'HK1']",0.9991746621801322,0,0,4
113,ACE Inhibitor Pathway WP554,0.4823572066419585,1.8642501776830136,1.3591695235408974,['ATP6AP2'],0.9991746621801322,0,0,1
114,Acetylcholine Synthesis WP528,0.4823572066419585,1.8642501776830136,1.3591695235408974,['CHKA'],0.9991746621801322,0,0,1
115,Caloric restriction and aging WP4191,0.4823572066419585,1.8642501776830136,1.3591695235408974,['NAMPT'],0.9991746621801322,0,0,1
116,"Cerebral organic acidurias, including diseases WP4519",0.4823572066419585,1.8642501776830136,1.3591695235408974,['MDH2'],0.9991746621801322,0,0,1
117,Disorders of the Krebs cycle WP4236,0.4823572066419585,1.8642501776830136,1.3591695235408974,['DHTKD1'],0.9991746621801322,0,0,1
118,Dopaminergic Neurogenesis WP2855,0.4823572066419585,1.8642501776830136,1.3591695235408974,['SOX2'],0.9991746621801322,0,0,1
119,Dual hijack model of Vif in HIV infection WP3300,0.4823572066419585,1.8642501776830136,1.3591695235408974,['ELOB'],0.9991746621801322,0,0,1
120,Estrogen Receptor Pathway WP2881,0.4823572066419585,1.8642501776830136,1.3591695235408974,['PPARA'],0.9991746621801322,0,0,1
121,Galanin receptor pathway WP4970,0.4823572066419585,1.8642501776830136,1.3591695235408974,['PRKCD'],0.9991746621801322,0,0,1
122,Hedgehog Signaling Pathway Netpath WP47,0.4823572066419585,1.8642501776830136,1.3591695235408974,['KIF7'],0.9991746621801322,0,0,1
123,Matrix Metalloproteinases WP129,0.4823572066419585,1.8642501776830136,1.3591695235408974,['MMP16'],0.9991746621801322,0,0,1
124,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4823572066419585,1.8642501776830136,1.3591695235408974,['VEGFB'],0.9991746621801322,0,0,1
125,miR-509-3p alteration of YAP1/ECM axis WP3967,0.4823572066419585,1.8642501776830136,1.3591695235408974,['COL5A1'],0.9991746621801322,0,0,1
126,Mitochondrial fatty acid synthesis pathway WP4317,0.4823572066419585,1.8642501776830136,1.3591695235408974,['HSD17B12'],0.9991746621801322,0,0,1
127,Mesodermal commitment pathway WP2857,0.4843715884019475,1.0875953743443014,0.7884010650317936,"['SOX2', 'LATS1', 'LEFTY1', 'ARL4A', 'TRIM28', 'RPL38', 'ACVR2A']",0.9991746621801322,0,0,7
128,Apoptosis Modulation and Signaling WP1772,0.48653035554518703,1.1186295503211992,0.8059233528782173,"['ENDOG', 'CASP6', 'TRAF3', 'BAD', 'CYCS']",0.9991746621801322,0,0,5
129,NO/cGMP/PKG mediated Neuroprotection WP4008,0.48861370874481186,1.198489010989011,0.8583375312915537,"['BAD', 'CAMK2A', 'CYCS']",0.9991746621801322,0,0,3
130,Ciliary landscape WP4352,0.49472798953673,1.0357543690877025,0.728909220084887,"['NDUFA5', 'SSNA1', 'CAMK2A', 'COPS7A', 'MYL6B', 'WDR34', 'COX6C', 'LSM4', 'MYL6', 'WNK1', 'XPNPEP3', 'TNKS1BP1', 'DVL3', 'SNRPB2', 'DCAF11']",0.9991746621801322,0,0,15
131,Ectoderm Differentiation WP2858,0.5049683840065246,1.0485887096774194,0.716458153013684,"['SOX2', 'GREB1', 'ARHGDIG', 'PIM1', 'DMD', 'ROR2', 'NR2F2', 'NF2', 'MZF1']",0.9991746621801322,0,0,9
132,Exercise-induced Circadian Regulation WP410,0.5050125672675984,1.1185026737967914,0.7641296687750682,"['DAZAP2', 'HSPA8', 'SUMO1', 'GSTP1']",0.9991746621801322,0,0,4
133,Neural Crest Differentiation WP2064,0.5050125672675984,1.1185026737967914,0.7641296687750682,"['LHX2', 'DVL3', 'MBP', 'HDAC8']",0.9991746621801322,0,0,4
134,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5050125672675984,1.1185026737967914,0.7641296687750682,"['PRKCG', 'IFI27L2', 'PRKCD', 'CAMK2A']",0.9991746621801322,0,0,4
135,Fluoropyrimidine Activity WP1601,0.5146190178588975,1.2427368670698447,0.8255854233926271,"['TDG', 'CES2']",0.9991746621801322,0,0,2
136,GDNF/RET signaling axis WP4830,0.5146190178588975,1.2427368670698447,0.8255854233926271,"['ROBO2', 'FAT4']",0.9991746621801322,0,0,2
137,TLR4 Signaling and Tolerance WP3851,0.5146190178588975,1.2427368670698447,0.8255854233926271,"['IRF3', 'TRAF3']",0.9991746621801322,0,0,2
138,ErbB signaling pathway WP673,0.5171648916004822,1.0753994399604678,0.7091114178824454,"['PRKCG', 'BTC', 'ERBB4', 'BAD', 'CAMK2A']",0.9991746621801322,0,0,5
139,Senescence and Autophagy in Cancer WP615,0.5269806176039838,1.0484324758842443,0.6716169427100082,"['GABARAPL1', 'MAP1LC3A', 'PCNA', 'IGFBP5', 'SQSTM1', 'ATG7']",0.9991746621801322,0,0,6
140,GABA receptor Signaling WP4159,0.5289264237940577,1.1183760683760684,0.7123003636218002,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9991746621801322,0,0,3
141,IL-6 signaling pathway WP364,0.5289264237940577,1.1183760683760684,0.7123003636218002,"['BAD', 'PRKCD', 'VIP']",0.9991746621801322,0,0,3
142,Wnt signaling pathway and pluripotency WP399,0.538946107748463,1.0650369238604533,0.6583416032156505,"['SOX2', 'PRKCG', 'PRKCD', 'DVL3']",0.9991746621801322,0,0,4
143,Alzheimer's disease WP2059,0.5470022308011439,1.0353715599968276,0.6246421452998638,"['ATP5MD', 'APH1A', 'BAD', 'CHP1', 'CYCS']",0.9991746621801322,0,0,5
144,Pathways Regulating Hippo Signaling WP4540,0.5539020234210152,1.0164669200038976,0.6004955814254953,"['PRKCG', 'LATS1', 'PRKCD', 'CDH11', 'NF2', 'STK3']",0.9991746621801322,0,0,6
145,Aspirin and miRNAs WP4707,0.5609577242063571,1.3979211087420043,0.8081518006352608,['PPARA'],0.9991746621801322,0,0,1
146,Autosomal recessive Osteopetrosis pathways WP4788,0.5609577242063571,1.3979211087420043,0.8081518006352608,['OSTM1'],0.9991746621801322,0,0,1
147,Cysteine and methionine catabolism WP4504,0.5609577242063571,1.3979211087420043,0.8081518006352608,['GSS'],0.9991746621801322,0,0,1
148,Genes targeted by miRNAs in adipocytes WP1992,0.5609577242063571,1.3979211087420043,0.8081518006352608,['TMSB4X'],0.9991746621801322,0,0,1
149,Glial Cell Differentiation WP2276,0.5609577242063571,1.3979211087420043,0.8081518006352608,['MBP'],0.9991746621801322,0,0,1
150,Heart Development WP1591,0.5609577242063571,1.3979211087420043,0.8081518006352608,['VEGFB'],0.9991746621801322,0,0,1
151,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5609577242063571,1.3979211087420043,0.8081518006352608,['RPS6'],0.9991746621801322,0,0,1
152,Insulin signaling in adipocytes (normal condition) WP3634,0.5609577242063571,1.3979211087420043,0.8081518006352608,['RPS6'],0.9991746621801322,0,0,1
153,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5609577242063571,1.3979211087420043,0.8081518006352608,['ERBB4'],0.9991746621801322,0,0,1
154,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5609577242063571,1.3979211087420043,0.8081518006352608,['IRF3'],0.9991746621801322,0,0,1
155,Transcriptional cascade regulating adipogenesis WP4211,0.5609577242063571,1.3979211087420043,0.8081518006352608,['DDIT3'],0.9991746621801322,0,0,1
156,Allograft Rejection WP2328,0.5635216381861564,1.1182497331910353,0.6413716274785856,"['COL5A1', 'HLA-B']",0.9991746621801322,0,0,2
157,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5635216381861564,1.1182497331910353,0.6413716274785856,"['LDHA', 'RPS6']",0.9991746621801322,0,0,2
158,Notch Signaling WP268,0.5635216381861564,1.1182497331910353,0.6413716274785856,"['APH1A', 'DVL3']",0.9991746621801322,0,0,2
159,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5635216381861564,1.1182497331910353,0.6413716274785856,"['NDUFA13', 'AAMP']",0.9991746621801322,0,0,2
160,The influence of laminopathies on Wnt signaling WP4844,0.5635216381861564,1.1182497331910353,0.6413716274785856,"['CDK6', 'ZMPSTE24']",0.9991746621801322,0,0,2
161,Development of ureteric collection system WP5053,0.5673982761597964,1.0482772435897436,0.5940522091212409,"['ROBO2', 'GDF11', 'FAT4']",0.9991746621801322,0,0,3
162,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5673982761597964,1.0482772435897436,0.5940522091212409,"['DEPTOR', 'MAP1LC3A', 'IGFBP5']",0.9991746621801322,0,0,3
163,Acute viral myocarditis WP4298,0.5716568115248792,1.0164316966456004,0.5684053225386637,"['ENDOG', 'CASP6', 'CYCS', 'DMD']",0.9991746621801322,0,0,4
164,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5804397208680842,0.9747348147930343,0.5302258375574835,"['ATF2', 'RPL5', 'SET', 'ITGB5', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'WASF1', 'CCT7', 'RAB4A', 'TRPC3', 'PRKCD', 'RPS6', 'PDIA6', 'INPP4B', 'RCN1', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'EIF3D', 'PTMA']",0.9991746621801322,0,0,26
165,MAPK Signaling Pathway WP382,0.6022608716121456,0.9577438742487286,0.4856380010806144,"['PRKCG', 'DUSP4', 'ATF2', 'HSPA8', 'DUSP3', 'DDIT3', 'RASGRF2', 'PRKCD', 'FGF1', 'RASGRP2', 'NGF', 'STK3']",0.9991746621801322,0,0,12
166,Retinoblastoma gene in cancer WP2446,0.603023319852146,0.9720530109276913,0.49166383936517605,"['PCNA', 'CDK6', 'E2F3', 'SAP30']",0.9991746621801322,0,0,4
167,16p11.2 proximal deletion syndrome WP4949,0.6038494115791901,0.9635974304068522,0.48606786685104786,"['UNC13B', 'PCNA', 'TMEM219', 'SEZ6L2', 'CCT7']",0.9991746621801322,0,0,5
168,ATM Signaling Network in Development and Disease  WP3878,0.6038723024370236,0.9864253393665159,0.4975455658773055,"['ATF2', 'DCLRE1C', 'TRIM28']",0.9991746621801322,0,0,3
169,Amyotrophic lateral sclerosis (ALS) WP2447,0.608776136991927,1.0163966236538275,0.5044423908882605,"['TOMM40', 'BAD']",0.9991746621801322,0,0,2
170,Cardiac Progenitor Differentiation WP2406,0.608776136991927,1.0163966236538275,0.5044423908882605,"['SOX2', 'ROR2']",0.9991746621801322,0,0,2
171,Complement system WP2806,0.608776136991927,1.0163966236538275,0.5044423908882605,"['RPS19', 'CD59']",0.9991746621801322,0,0,2
172,Differentiation Pathway WP2848,0.608776136991927,1.0163966236538275,0.5044423908882605,"['LEFTY1', 'FGF1']",0.9991746621801322,0,0,2
173,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.608776136991927,1.0163966236538275,0.5044423908882605,"['IRF3', 'TRAF3']",0.9991746621801322,0,0,2
174,Nuclear receptors WP170,0.608776136991927,1.0163966236538275,0.5044423908882605,"['NR2F2', 'PPARA']",0.9991746621801322,0,0,2
175,PKC-gamma calcium signaling pathway in ataxia WP4760,0.608776136991927,1.0163966236538275,0.5044423908882605,"['PRKCG', 'TRPC3']",0.9991746621801322,0,0,2
176,Pre-implantation embryo WP3527,0.608776136991927,1.0163966236538275,0.5044423908882605,"['SOX2', 'DDIT3']",0.9991746621801322,0,0,2
177,Myometrial relaxation and contraction pathways WP289,0.6148411625339292,0.9468902227655033,0.46055918235024373,"['PRKCG', 'ATF2', 'RGS17', 'IGFBP5', 'GRK4', 'GSTO1', 'PRKCD', 'CAMK2A', 'LPAR1', 'CRH']",0.9991746621801322,0,0,10
178,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6276340393609904,1.1181236673773987,0.5208197928884256,['SST'],0.9991746621801322,0,0,1
179,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6276340393609904,1.1181236673773987,0.5208197928884256,['RPH3AL'],0.9991746621801322,0,0,1
180,HIF1A and PPARG regulation of glycolysis WP2456,0.6276340393609904,1.1181236673773987,0.5208197928884256,['LDHA'],0.9991746621801322,0,0,1
181,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.6276340393609904,1.1181236673773987,0.5208197928884256,['SQSTM1'],0.9991746621801322,0,0,1
182,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6276340393609904,1.1181236673773987,0.5208197928884256,['ERBB4'],0.9991746621801322,0,0,1
183,"NAD metabolism, sirtuins and aging WP3630",0.6276340393609904,1.1181236673773987,0.5208197928884256,['NAMPT'],0.9991746621801322,0,0,1
184,NAD+ biosynthetic pathways WP3645,0.6276340393609904,1.1181236673773987,0.5208197928884256,['NAMPT'],0.9991746621801322,0,0,1
185,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6276340393609904,1.1181236673773987,0.5208197928884256,['LDHA'],0.9991746621801322,0,0,1
186,PPAR-alpha pathway WP2878,0.6276340393609904,1.1181236673773987,0.5208197928884256,['PPARA'],0.9991746621801322,0,0,1
187,Purinergic signaling WP4900,0.6276340393609904,1.1181236673773987,0.5208197928884256,['PANX1'],0.9991746621801322,0,0,1
188,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6276340393609904,1.1181236673773987,0.5208197928884256,['IRF3'],0.9991746621801322,0,0,1
189,Wnt signaling in kidney disease WP4150,0.6276340393609904,1.1181236673773987,0.5208197928884256,['DVL3'],0.9991746621801322,0,0,1
190,Fragile X Syndrome  WP4549,0.6311269697399302,0.931077694235589,0.4285268484833293,"['DEPTOR', 'DUSP3', 'ALDH5A1', 'CAMK2A', 'AP2S1', 'AKAP5', 'DLGAP3', 'AP2M1']",0.9991746621801322,0,0,8
191,mRNA Processing WP411,0.6323479261926279,0.9310035842293907,0.4266933920012312,"['LSM7', 'SF3A1', 'CELF1', 'HNRNPA2B1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'SRSF9']",0.9991746621801322,0,0,9
192,Ethanol effects on histone modifications WP3996,0.6503626344633724,0.9315190323728211,0.40076293637651567,"['ATF2', 'HDAC8']",0.9991746621801322,0,0,2
193,Monoamine GPCRs WP58,0.6503626344633724,0.9315190323728211,0.40076293637651567,"['HTR2C', 'HTR5A']",0.9991746621801322,0,0,2
194,Unfolded protein response WP4925,0.6503626344633724,0.9315190323728211,0.40076293637651567,"['DDIT3', 'EIF2S1']",0.9991746621801322,0,0,2
195,IL-18 signaling pathway WP4754,0.6541205539454282,0.9178525513144479,0.38959500853727735,"['LARS2', 'TOMM40', 'GRM7', 'PHF20', 'NACA', 'BAD', 'TSHZ1', 'TMSB4X', 'PRKCD', 'CYCS', 'NDUFC1', 'RND2']",0.9991746621801322,0,0,12
196,Wnt signaling WP428,0.6613908680070016,0.8939465240641711,0.369566687820095,"['PRKCG', 'CAMK2A', 'DVL3', 'ROR2']",0.9991746621801322,0,0,4
197,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.670477592467604,0.8822537112010796,0.3526941512916858,"['PRKCD', 'RPS6', 'PIM1']",0.9991746621801322,0,0,3
198,Biomarkers for pyrimidine metabolism disorders WP4584,0.6841934914302426,0.931592039800995,0.35355270503394004,['PUS1'],0.9991746621801322,0,0,1
199,Differentiation of white and brown adipocyte WP2895,0.6841934914302426,0.931592039800995,0.35355270503394004,['PPARGC1B'],0.9991746621801322,0,0,1
200,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6841934914302426,0.931592039800995,0.35355270503394004,['ENPP1'],0.9991746621801322,0,0,1
201,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6841934914302426,0.931592039800995,0.35355270503394004,['GRM7'],0.9991746621801322,0,0,1
202,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6841934914302426,0.931592039800995,0.35355270503394004,['BAD'],0.9991746621801322,0,0,1
203,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6841934914302426,0.931592039800995,0.35355270503394004,['EIF2AK1'],0.9991746621801322,0,0,1
204,miRNAs involved in DNA damage response WP1545,0.6841934914302426,0.931592039800995,0.35355270503394004,['CDK6'],0.9991746621801322,0,0,1
205,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6841934914302426,0.931592039800995,0.35355270503394004,['PPARA'],0.9991746621801322,0,0,1
206,Signal Transduction of S1P Receptor WP26,0.6841934914302426,0.931592039800995,0.35355270503394004,['ASAH1'],0.9991746621801322,0,0,1
207,Tryptophan catabolism leading to NAD+ production WP4210,0.6841934914302426,0.931592039800995,0.35355270503394004,['NAMPT'],0.9991746621801322,0,0,1
208,Urea cycle and associated pathways WP4595,0.6841934914302426,0.931592039800995,0.35355270503394004,['MDH2'],0.9991746621801322,0,0,1
209,Urea cycle and metabolism of amino groups WP497,0.6841934914302426,0.931592039800995,0.35355270503394004,['ODC1'],0.9991746621801322,0,0,1
210,Corticotropin-releasing hormone signaling pathway WP2355,0.6882924604458618,0.8593994241053065,0.32102130143684293,"['TRIM28', 'PRKCD', 'CAMK2A', 'CRH']",0.9991746621801322,0,0,4
211,Melanoma WP4685,0.6882924604458618,0.8593994241053065,0.32102130143684293,"['CDK6', 'ERBB4', 'BAD', 'E2F3']",0.9991746621801322,0,0,4
212,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6883512016374735,0.8596995320581233,0.3210600376782525,"['RAB4A', 'RABAC1']",0.9991746621801322,0,0,2
213,Type 2 papillary renal cell carcinoma WP4241,0.6883512016374735,0.8596995320581233,0.3210600376782525,"['COL21A1', 'ELOB']",0.9991746621801322,0,0,2
214,EGF/EGFR signaling pathway WP437,0.6937518561053779,0.8685741535526943,0.31758626862524886,"['NDUFA13', 'PCNA', 'PRKCD', 'CAMK2A', 'AP2S1', 'NEDD8', 'AP2M1']",0.9991746621801322,0,0,7
215,Metabolic reprogramming in colon cancer WP4290,0.7005474754730102,0.8379807692307693,0.29823160873546045,"['LDHA', 'MDH2', 'IDH3A']",0.9991746621801322,0,0,3
216,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.713644667106961,0.8274113685878391,0.27914386082427683,"['PRKCG', 'BAD', 'RPS6', 'PDGFC']",0.9991746621801322,0,0,4
217,Copper homeostasis WP3286,0.7228750678051195,0.7981399603598109,0.25901147700384236,"['COMMD1', 'ATOX1']",0.9991746621801322,0,0,2
218,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7228750678051195,0.7981399603598109,0.25901147700384236,"['PRKCG', 'PRKCD']",0.9991746621801322,0,0,2
219,p38 MAPK Signaling Pathway WP400,0.7228750678051195,0.7981399603598109,0.25901147700384236,"['ATF2', 'DDIT3']",0.9991746621801322,0,0,2
220,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7228750678051195,0.7981399603598109,0.25901147700384236,"['IRF3', 'TRAF3']",0.9991746621801322,0,0,2
221,Ebola Virus Pathway on Host WP4217,0.7263564393661363,0.8211046731326364,0.2625190054188051,"['IRF3', 'HLA-B', 'DAB2IP', 'MERTK', 'EIF2S1']",0.9991746621801322,0,0,5
222,Pathways in clear cell renal cell carcinoma WP4018,0.7263564393661363,0.8211046731326364,0.2625190054188051,"['LDHA', 'DEPTOR', 'ALDOC', 'SQSTM1', 'HK1']",0.9991746621801322,0,0,5
223,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7284810025170719,0.797924297924298,0.25277741557060995,"['CDK6', 'DVL3', 'ROR2']",0.9991746621801322,0,0,3
224,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7319090514374018,0.8312939457583782,0.2594460253129078,"['BAD', 'RPS6', 'PRKCD', 'CAMK2A', 'NGF', 'SQSTM1', 'EIF2S1']",0.9991746621801322,0,0,7
225,miRNAs involvement in the immune response in sepsis WP4329,0.7321697315194197,0.7983551629607066,0.2488815682925099,['TRAF3'],0.9991746621801322,0,0,1
226,Sleep regulation WP3591,0.7321697315194197,0.7983551629607066,0.2488815682925099,['CRH'],0.9991746621801322,0,0,1
227,Striated Muscle Contraction Pathway WP383,0.7321697315194197,0.7983551629607066,0.2488815682925099,['DMD'],0.9991746621801322,0,0,1
228,Trans-sulfuration and one-carbon metabolism WP2525,0.7321697315194197,0.7983551629607066,0.2488815682925099,['GSS'],0.9991746621801322,0,0,1
229,Photodynamic therapy-induced unfolded protein response WP3613,0.7541098751344383,0.7447883315546069,0.2101920764818851,"['DDIT3', 'PDIA6']",0.9991746621801322,0,0,2
230,AGE/RAGE pathway WP2324,0.754326637874848,0.761509324009324,0.21469216993156578,"['ATF2', 'PRKCD', 'CYCS']",0.9991746621801322,0,0,3
231,G1 to S cell cycle control WP45,0.754326637874848,0.761509324009324,0.21469216993156578,"['PCNA', 'CDK6', 'E2F3']",0.9991746621801322,0,0,3
232,Small cell lung cancer WP4658,0.7597296201008981,0.7700534759358288,0.21160505225498652,"['CDK6', 'TRAF3', 'CYCS', 'E2F3']",0.9991746621801322,0,0,4
233,Hepatitis B infection WP4666,0.7666449262823414,0.7970570202329859,0.21180317603037319,"['PRKCG', 'ATF2', 'PCNA', 'IRF3', 'TRAF3', 'BAD', 'CYCS']",0.9991746621801322,0,0,7
234,Hippo-Merlin Signaling Dysregulation WP4541,0.7669394801335067,0.7751903402331668,0.2056947299511086,"['LATS1', 'ITGB5', 'CDH11', 'NF2', 'STK3']",0.9991746621801322,0,0,5
235,16p11.2 distal deletion syndrome WP4950,0.7728641299108965,0.6984275053304904,0.1799512545600945,['RAB4A'],0.9991746621801322,0,0,1
236,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7728641299108965,0.6984275053304904,0.1799512545600945,['RPS6'],0.9991746621801322,0,0,1
237,Gastric Cancer Network 1 WP2361,0.7728641299108965,0.6984275053304904,0.1799512545600945,['SMOC2'],0.9991746621801322,0,0,1
238,Hedgehog Signaling Pathway WP4249,0.7728641299108965,0.6984275053304904,0.1799512545600945,['KIF7'],0.9991746621801322,0,0,1
239,IL-7 signaling pathway WP205,0.7728641299108965,0.6984275053304904,0.1799512545600945,['BAD'],0.9991746621801322,0,0,1
240,Immune response to tuberculosis WP4197,0.7728641299108965,0.6984275053304904,0.1799512545600945,['PTPN2'],0.9991746621801322,0,0,1
241,Monoamine Transport WP727,0.7728641299108965,0.6984275053304904,0.1799512545600945,['UNC13B'],0.9991746621801322,0,0,1
242,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7728641299108965,0.6984275053304904,0.1799512545600945,['GSTP1'],0.9991746621801322,0,0,1
243,Pregnane X receptor pathway WP2876,0.7728641299108965,0.6984275053304904,0.1799512545600945,['PSMC5'],0.9991746621801322,0,0,1
244,Prostaglandin Synthesis and Regulation WP98,0.7728641299108965,0.6984275053304904,0.1799512545600945,['PPARGC1B'],0.9991746621801322,0,0,1
245,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.7728641299108965,0.6984275053304904,0.1799512545600945,['PPARA'],0.9991746621801322,0,0,1
246,Pancreatic adenocarcinoma pathway WP4263,0.78051362017232,0.7442424242424243,0.18442557139873345,"['CDK6', 'BAD', 'PRKCD', 'E2F3']",0.9991746621801322,0,0,4
247,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.78051362017232,0.7442424242424243,0.18442557139873345,"['HSPA8', 'PSMC5', 'PSMC1', 'UBE2J1']",0.9991746621801322,0,0,4
248,Genotoxicity pathway WP4286,0.7822577651245833,0.6981056563500534,0.1714344830730379,"['RPS27', 'PHLDA3']",0.9991746621801322,0,0,2
249,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7822577651245833,0.6981056563500534,0.1714344830730379,"['LDHA', 'HK1']",0.9991746621801322,0,0,2
250,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7822577651245833,0.6981056563500534,0.1714344830730379,"['ATF2', 'CAMK2A']",0.9991746621801322,0,0,2
251,Adipogenesis WP236,0.8027840312513241,0.7341090950073256,0.16126141717489204,"['CELF1', 'DDIT3', 'NAMPT', 'PPARA', 'ZMPSTE24']",0.9991746621801322,0,0,5
252,Integrated breast cancer pathway WP1984,0.8072237267129659,0.7436941764916042,0.15926539244193533,"['FER', 'BAD', 'DCAKD', 'ODC1', 'FAU', 'DHTKD1']",0.9991746621801322,0,0,6
253,Alpha 6 Beta 4 signaling pathway WP244,0.8073809244769139,0.6207059938403222,0.13280606618629343,['PRKCD'],0.9991746621801322,0,0,1
254,FOXA2 pathway WP5066,0.8073809244769139,0.6207059938403222,0.13280606618629343,['PPARGC1B'],0.9991746621801322,0,0,1
255,Imatinib and Chronic Myeloid Leukemia WP3640,0.8073809244769139,0.6207059938403222,0.13280606618629343,['PIM1'],0.9991746621801322,0,0,1
256,NOTCH1 regulation of endothelial cell calcification WP3413,0.8073809244769139,0.6207059938403222,0.13280606618629343,['LPAR1'],0.9991746621801322,0,0,1
257,Oxidation by Cytochrome P450 WP43,0.8073809244769139,0.6207059938403222,0.13280606618629343,['CYP4Z1'],0.9991746621801322,0,0,1
258,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8073809244769139,0.6207059938403222,0.13280606618629343,['HTR2C'],0.9991746621801322,0,0,1
259,Sphingolipid Metabolism (general overview) WP4725,0.8073809244769139,0.6207059938403222,0.13280606618629343,['ASAH1'],0.9991746621801322,0,0,1
260,Sphingolipid Metabolism (integrated pathway) WP4726,0.8073809244769139,0.6207059938403222,0.13280606618629343,['ASAH1'],0.9991746621801322,0,0,1
261,TP53 network WP1742,0.8073809244769139,0.6207059938403222,0.13280606618629343,['SUMO1'],0.9991746621801322,0,0,1
262,Disruption of postsynaptic signaling by CNV WP4875,0.8075353099761925,0.6569150605813296,0.1404277453651464,"['NLGN2', 'CAMK2A']",0.9991746621801322,0,0,2
263,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8075353099761925,0.6569150605813296,0.1404277453651464,"['DVL3', 'ROR2']",0.9991746621801322,0,0,2
264,Nephrotic syndrome WP4758,0.8075353099761925,0.6569150605813296,0.1404277453651464,"['E2F3', 'ZMPSTE24']",0.9991746621801322,0,0,2
265,Thermogenesis WP4321,0.8177768657816363,0.6974598930481284,0.14030504932114185,"['ATF2', 'RPS6', 'ZNF516', 'CPT1B']",0.9991746621801322,0,0,4
266,Common Pathways Underlying Drug Addiction WP2636,0.8301644905037466,0.6203011976757975,0.11545754057818412,"['PRKCG', 'CAMK2A']",0.9991746621801322,0,0,2
267,IL-4 signaling pathway WP395,0.8301644905037466,0.6203011976757975,0.11545754057818412,"['ATF2', 'BAD']",0.9991746621801322,0,0,2
268,Kit receptor signaling pathway WP304,0.8301644905037466,0.6203011976757975,0.11545754057818412,"['BAD', 'RPS6']",0.9991746621801322,0,0,2
269,PPAR signaling pathway WP3942,0.8301644905037466,0.6203011976757975,0.11545754057818412,"['PPARA', 'CPT1B']",0.9991746621801322,0,0,2
270,Regulation of Microtubule Cytoskeleton WP2038,0.8301644905037466,0.6203011976757975,0.11545754057818412,"['PARD6A', 'MAPRE1']",0.9991746621801322,0,0,2
271,G Protein Signaling Pathways WP35,0.8343652540849035,0.6761951061416303,0.12244812674449725,"['PRKCG', 'PRKCD', 'AKAP5', 'PDE7B']",0.9991746621801322,0,0,4
272,BDNF-TrkB Signaling WP3676,0.8366570550800078,0.5585287846481877,0.09960859513215448,['TRPC3'],0.9991746621801322,0,0,1
273,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.8366570550800078,0.5585287846481877,0.09960859513215448,['BCL6'],0.9991746621801322,0,0,1
274,Glycerolipids and Glycerophospholipids WP4722,0.8366570550800078,0.5585287846481877,0.09960859513215448,['ETNK1'],0.9991746621801322,0,0,1
275,Glycerophospholipid Biosynthetic Pathway WP2533,0.8366570550800078,0.5585287846481877,0.09960859513215448,['PIP5K1A'],0.9991746621801322,0,0,1
276,Melatonin metabolism and effects WP3298,0.8366570550800078,0.5585287846481877,0.09960859513215448,['CAMK2A'],0.9991746621801322,0,0,1
277,Methionine De Novo and Salvage Pathway WP3580,0.8366570550800078,0.5585287846481877,0.09960859513215448,['ODC1'],0.9991746621801322,0,0,1
278,Nanoparticle-mediated activation of receptor signaling WP2643,0.8366570550800078,0.5585287846481877,0.09960859513215448,['TLN1'],0.9991746621801322,0,0,1
279,Phosphoinositides metabolism WP4971,0.8366570550800078,0.5585287846481877,0.09960859513215448,['PIP5K1A'],0.9991746621801322,0,0,1
280,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8366570550800078,0.5585287846481877,0.09960859513215448,['BAD'],0.9991746621801322,0,0,1
281,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8366570550800078,0.5585287846481877,0.09960859513215448,['RPS6'],0.9991746621801322,0,0,1
282,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8366570550800078,0.5585287846481877,0.09960859513215448,['TRAF3'],0.9991746621801322,0,0,1
283,Tryptophan metabolism WP465,0.8366570550800078,0.5585287846481877,0.09960859513215448,['OGDH'],0.9991746621801322,0,0,1
284,NRF2 pathway WP2884,0.8481996622981307,0.6800020891001202,0.11195501360300433,"['GSTP1', 'SLC39A11', 'BLVRB', 'SQSTM1', 'CES2']",0.9991746621801322,0,0,5
285,"GPCRs, Class A Rhodopsin-like WP455",0.8496732644842433,0.6561811890531614,0.10689414547969707,"['MC1R', 'HTR2C', 'HTR5A', 'MCHR1']",0.9991746621801322,0,0,4
286,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8503660751950862,0.5875414256024265,0.0952336175958145,"['ERBB4', 'TMSB4X']",0.9991746621801322,0,0,2
287,Notch Signaling Pathway Netpath WP61,0.8503660751950862,0.5875414256024265,0.0952336175958145,"['APH1A', 'SAP30']",0.9991746621801322,0,0,2
288,Proximal tubule transport WP4917,0.8503660751950862,0.5875414256024265,0.0952336175958145,"['SLC13A3', 'ATP6V1F']",0.9991746621801322,0,0,2
289,RANKL/RANK signaling pathway WP2018,0.8503660751950862,0.5875414256024265,0.0952336175958145,"['TRAF3', 'SQSTM1']",0.9991746621801322,0,0,2
290,Rett syndrome causing genes WP4312,0.8503660751950862,0.5875414256024265,0.0952336175958145,"['GPS2', 'HDAC8']",0.9991746621801322,0,0,2
291,Head and Neck Squamous Cell Carcinoma WP4674,0.8550862479489068,0.6198955365622032,0.09704646895174433,"['CDK6', 'TRAF3', 'RPS6']",0.9991746621801322,0,0,3
292,Regulation of Actin Cytoskeleton WP51,0.8612721535078911,0.6636841031915979,0.09911772616944928,"['TMSB4X', 'PIP5K1A', 'BRK1', 'FGF1', 'WASF1']",0.9991746621801322,0,0,5
293,7-oxo-C and 7beta-HC pathways WP5064,0.8614874875416525,0.5076565225818958,0.07568892087703868,['EPHX2'],0.9991746621801322,0,0,1
294,Fatty acid beta-oxidation WP143,0.8614874875416525,0.5076565225818958,0.07568892087703868,['CPT1B'],0.9991746621801322,0,0,1
295,Gastric Cancer Network 2 WP2363,0.8614874875416525,0.5076565225818958,0.07568892087703868,['OTUD5'],0.9991746621801322,0,0,1
296,Genes controlling nephrogenesis WP4823,0.8614874875416525,0.5076565225818958,0.07568892087703868,['ROBO2'],0.9991746621801322,0,0,1
297,Glycosylation and related congenital defects WP4521,0.8614874875416525,0.5076565225818958,0.07568892087703868,['MAGT1'],0.9991746621801322,0,0,1
298,IL17 signaling pathway WP2112,0.8614874875416525,0.5076565225818958,0.07568892087703868,['TRAF3'],0.9991746621801322,0,0,1
299,DNA IR-damage and cellular response via ATR WP4016,0.8702406685184859,0.5976419413919414,0.0830635491686149,"['PCNA', 'TRIM28', 'BCL6']",0.9991746621801322,0,0,3
300,Glioblastoma signaling pathways WP2261,0.8702406685184859,0.5976419413919414,0.0830635491686149,"['PRKCG', 'CDK6', 'PRKCD']",0.9991746621801322,0,0,3
301,Folate Metabolism WP176,0.8825467071213926,0.4652629708599858,0.058131614548169216,['GPX4'],0.9991746621801322,0,0,1
302,IL-2 signaling pathway WP49,0.8825467071213926,0.4652629708599858,0.058131614548169216,['RPS6'],0.9991746621801322,0,0,1
303,Integrated Cancer Pathway WP1971,0.8825467071213926,0.4652629708599858,0.058131614548169216,['BAD'],0.9991746621801322,0,0,1
304,Intraflagellar transport proteins binding to dynein WP4532,0.8825467071213926,0.4652629708599858,0.058131614548169216,['WDR34'],0.9991746621801322,0,0,1
305,Lung fibrosis WP3624,0.8825467071213926,0.4652629708599858,0.058131614548169216,['FGF1'],0.9991746621801322,0,0,1
306,Netrin-UNC5B signaling pathway WP4747,0.8825467071213926,0.4652629708599858,0.058131614548169216,['DAPK1'],0.9991746621801322,0,0,1
307,Peptide GPCRs WP24,0.8825467071213926,0.4652629708599858,0.058131614548169216,['MC1R'],0.9991746621801322,0,0,1
308,Sphingolipid pathway WP1422,0.8825467071213926,0.4652629708599858,0.058131614548169216,['ASAH1'],0.9991746621801322,0,0,1
309,Tumor suppressor activity of SMARCB1 WP4204,0.8825467071213926,0.4652629708599858,0.058131614548169216,['CDK6'],0.9991746621801322,0,0,1
310,Osteoblast differentiation WP4787,0.8839775270169964,0.5769230769230769,0.071148253035064,"['PRKCG', 'PRKCD', 'FGF1']",0.9991746621801322,0,0,3
311,DNA damage response WP707,0.8843364953792983,0.5313818163337907,0.0653161976825642,"['CDK6', 'CYCS']",0.9991746621801322,0,0,2
312,Endometrial cancer WP4155,0.8843364953792983,0.5313818163337907,0.0653161976825642,"['BAD', 'FGF1']",0.9991746621801322,0,0,2
313,IL-1 signaling pathway WP195,0.8843364953792983,0.5313818163337907,0.0653161976825642,"['ATF2', 'SQSTM1']",0.9991746621801322,0,0,2
314,MET in type 1 papillary renal cell carcinoma WP4205,0.8843364953792983,0.5313818163337907,0.0653161976825642,"['BAD', 'RPL11']",0.9991746621801322,0,0,2
315,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8843364953792983,0.5313818163337907,0.0653161976825642,"['ATF2', 'MBP']",0.9991746621801322,0,0,2
316,Breast cancer pathway WP4262,0.8885801281763008,0.6026304379245556,0.07118900590048693,"['CDK6', 'DVL3', 'E2F3', 'FGF1']",0.9991746621801322,0,0,4
317,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8915742458966273,0.717681038382573,0.08236578621584914,"['PFKFB2', 'ATF2', 'COL5A1', 'ITGB5', 'PIK3IP1', 'BAD', 'PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.9991746621801322,0,0,12
318,3q29 copy number variation syndrome WP4906,0.8985051339073042,0.5071310759677888,0.05427461759232455,"['NF2', 'WDR34']",0.9991746621801322,0,0,2
319,miRNA regulation of DNA damage response WP1530,0.8985051339073042,0.5071310759677888,0.05427461759232455,"['CDK6', 'CYCS']",0.9991746621801322,0,0,2
320,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8985051339073042,0.5071310759677888,0.05427461759232455,"['PCNA', 'TLN1']",0.9991746621801322,0,0,2
321,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8985051339073042,0.5071310759677888,0.05427461759232455,"['BAD', 'ANGPTL1']",0.9991746621801322,0,0,2
322,Bladder cancer WP2828,0.9004069612400186,0.4293915040183697,0.04504679227951691,['DAPK1'],0.9991746621801322,0,0,1
323,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9004069612400186,0.4293915040183697,0.04504679227951691,['IRF3'],0.9991746621801322,0,0,1
324,IL-5 signaling pathway WP127,0.9004069612400186,0.4293915040183697,0.04504679227951691,['RPS6'],0.9991746621801322,0,0,1
325,MAPK Cascade WP422,0.9004069612400186,0.4293915040183697,0.04504679227951691,['MBP'],0.9991746621801322,0,0,1
326,miRNA regulation of prostate cancer signaling pathways WP3981,0.9004069612400186,0.4293915040183697,0.04504679227951691,['BAD'],0.9991746621801322,0,0,1
327,Oxysterols derived from cholesterol WP4545,0.9004069612400186,0.4293915040183697,0.04504679227951691,['EPHX2'],0.9991746621801322,0,0,1
328,Splicing factor NOVA regulated synaptic proteins WP4148,0.9004069612400186,0.4293915040183697,0.04504679227951691,['NTNG1'],0.9991746621801322,0,0,1
329,Spinal Cord Injury WP2431,0.907617280925764,0.5394954507857733,0.052294635237570025,"['EFNB2', 'OMG', 'MBP']",0.9991746621801322,0,0,3
330,Calcium Regulation in the Cardiac Cell WP536,0.9087218629828067,0.6387813973123198,0.06114173624951618,"['PRKCG', 'SLC8A3', 'RGS17', 'GRK4', 'PRKCD', 'CAMK2A', 'ATP1B2']",0.9991746621801322,0,0,7
331,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9110423521051281,0.4849890956336133,0.04518444224598093,"['RNF7', 'SQSTM1']",0.9991746621801322,0,0,2
332,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9110423521051281,0.4849890956336133,0.04518444224598093,"['BAD', 'CYCS']",0.9991746621801322,0,0,2
333,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9110423521051281,0.4849890956336133,0.04518444224598093,"['DEPTOR', 'TRIM28']",0.9991746621801322,0,0,2
334,ATM Signaling Pathway WP2516,0.9155537428633965,0.3986445324398416,0.03517089754952219,['ATF2'],0.9991746621801322,0,0,1
335,Interleukin-11 Signaling Pathway WP2332,0.9155537428633965,0.3986445324398416,0.03517089754952219,['RPS6'],0.9991746621801322,0,0,1
336,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9155537428633965,0.3986445324398416,0.03517089754952219,['ATF2'],0.9991746621801322,0,0,1
337,Gastrin signaling pathway WP4659,0.9183849212395244,0.5571122994652407,0.04743180136620717,"['ATF2', 'BAD', 'RPS6', 'PRKCD']",0.9991746621801322,0,0,4
338,Vitamin D Receptor Pathway WP2877,0.9183849212395244,0.5571122994652407,0.04743180136620717,"['IGFBP5', 'BCL6', 'CLEC16A', 'CLPTM1L']",0.9991746621801322,0,0,4
339,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9213008945660158,0.5800544254104212,0.04754624446778544,"['SOX2', 'SST', 'NGF', 'SLC25A4', 'PPARGC1B']",0.9991746621801322,0,0,5
340,22q11.2 copy number variation syndrome WP4657,0.9221164141521745,0.46469228032728566,0.03767901627186893,"['RANBP1', 'MRPL40']",0.9991746621801322,0,0,2
341,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9221164141521745,0.46469228032728566,0.03767901627186893,"['ITGB5', 'DMD']",0.9991746621801322,0,0,2
342,DNA damage response (only ATM dependent) WP710,0.9268066253803856,0.5066045066045066,0.038507179671419145,"['BCL6', 'BAD', 'DVL3']",0.9991746621801322,0,0,3
343,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9283989304923285,0.37199715707178393,0.02763706623322241,['HDAC8'],0.9991746621801322,0,0,1
344,Pathogenic Escherichia coli infection WP2272,0.9283989304923285,0.37199715707178393,0.02763706623322241,['ARPC3'],0.9991746621801322,0,0,1
345,Vitamin D-sensitive calcium signaling in depression WP4698,0.9283989304923285,0.37199715707178393,0.02763706623322241,['GPX4'],0.9991746621801322,0,0,1
346,Oncostatin M Signaling Pathway WP2374,0.9318821424108691,0.44601921024546426,0.03146617756660954,"['PRKCD', 'RPS6']",0.9991746621801322,0,0,2
347,T-cell receptor (TCR) signaling pathway WP69,0.9318821424108691,0.44601921024546426,0.03146617756660954,"['ATF2', 'PRKCD']",0.9991746621801322,0,0,2
348,Toll-like Receptor Signaling Pathway WP75,0.9318821424108691,0.44601921024546426,0.03146617756660954,"['IRF3', 'TRAF3']",0.9991746621801322,0,0,2
349,Insulin Signaling WP481,0.9354507512228213,0.5566381156316916,0.03714266851953548,"['CYTH3', 'RAB4A', 'PRKCD', 'ENPP1', 'STX4']",0.9991746621801322,0,0,5
350,G13 Signaling Pathway WP524,0.9392919401393204,0.34868070362473347,0.021837503817757262,['ARHGDIG'],0.9991746621801322,0,0,1
351,IL-3 signaling pathway WP286,0.9392919401393204,0.34868070362473347,0.021837503817757262,['BAD'],0.9991746621801322,0,0,1
352,TGF-beta Receptor Signaling WP560,0.9392919401393204,0.34868070362473347,0.021837503817757262,['LEFTY1'],0.9991746621801322,0,0,1
353,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9392919401393204,0.34868070362473347,0.021837503817757262,['ZMPSTE24'],0.9991746621801322,0,0,1
354,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9404811181223544,0.4287825301699368,0.02631168549125941,"['ENPP1', 'SLC38A2']",0.9991746621801322,0,0,2
355,Endochondral Ossification WP474,0.9404811181223544,0.4287825301699368,0.02631168549125941,"['ENPP1', 'SLC38A2']",0.9991746621801322,0,0,2
356,Circadian rhythm related genes WP3594,0.9435940846672615,0.5656984031827348,0.03284399693761468,"['PRKCG', 'NAMPT', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.9991746621801322,0,0,6
357,Ras signaling WP4223,0.9435940846672615,0.5656984031827348,0.03284399693761468,"['PRKCG', 'RASA4', 'BAD', 'RASGRF2', 'KSR2', 'RASGRP2']",0.9991746621801322,0,0,6
358,Joubert Syndrome WP4656,0.9480421311942145,0.41282264121111506,0.022026703357458103,"['CEP120', 'DVL3']",0.9991746621801322,0,0,2
359,Aryl Hydrocarbon Receptor Netpath WP2586,0.9485291894473713,0.32810736234792426,0.017338084085829434,['PLAGL1'],0.9991746621801322,0,0,1
360,Focal Adhesion WP306,0.9487506547694254,0.5561629153269024,0.02925931948902966,"['PRKCG', 'ITGB5', 'BAD', 'PDGFC', 'VEGFB', 'TLN1']",0.9991746621801322,0,0,6
361,TGF-beta Signaling Pathway WP366,0.9488159432292961,0.46412037037037035,0.024385091863857088,"['ATF2', 'PARD6A', 'SUMO1']",0.9991746621801322,0,0,3
362,AMP-activated protein kinase (AMPK) signaling WP1403,0.954681797667688,0.3980027443207806,0.018458248966748494,"['CPT1B', 'PPARGC1B']",0.9991746621801322,0,0,2
363,ESC Pluripotency Pathways WP3931,0.954681797667688,0.3980027443207806,0.018458248966748494,"['DVL3', 'FGF1']",0.9991746621801322,0,0,2
364,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9563621289871846,0.3098199478796494,0.013823745228646156,['CHP1'],0.9991746621801322,0,0,1
365,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9563621289871846,0.3098199478796494,0.013823745228646156,['LEFTY1'],0.9991746621801322,0,0,1
366,PI3K-Akt signaling pathway WP4172,0.9585430593139813,0.6033837225628306,0.025547745815641974,"['ATF2', 'CDK6', 'ITGB5', 'BAD', 'PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.9991746621801322,0,0,10
367,TNF-alpha signaling pathway WP231,0.9605052850865227,0.384204909284952,0.01548184201513252,"['BAD', 'KSR2']",0.9991746621801322,0,0,2
368,"GPCRs, Other WP117",0.963004057559121,0.293457524408035,0.01106266014131589,['GPR61'],0.9991746621801322,0,0,1
369,Cell cycle WP179,0.9645284593599177,0.428172255095332,0.015463843568228516,"['CDK6', 'PCNA', 'E2F3']",0.9991746621801322,0,0,3
370,Ciliopathies WP4803,0.9653939756358767,0.5210008038585209,0.01834912525467598,"['XPNPEP3', 'CEP120', 'ALMS1', 'PKD1L1', 'KIF7', 'WDR34']",0.9991746621801322,0,0,6
371,Leptin signaling pathway WP2034,0.9656070976988765,0.37132692991817856,0.012995795943580203,"['BAD', 'RPS6']",0.9991746621801322,0,0,2
372,Interferon type I signaling pathways WP585,0.9686359057045777,0.27873134328358207,0.00888218677810857,['RPS6'],0.9991746621801322,0,0,1
373,Phosphodiesterases in neuronal function WP4222,0.9686359057045777,0.27873134328358207,0.00888218677810857,['PDE7B'],0.9991746621801322,0,0,1
374,Integrin-mediated Cell Adhesion WP185,0.9739752638769897,0.3479855923159018,0.009176161566534672,"['ITGB5', 'TLN1']",0.9991746621801322,0,0,2
375,Androgen receptor signaling pathway WP138,0.9773845872339433,0.337375893405776,0.007717494957778866,"['SUMO1', 'PARK7']",0.9991746621801322,0,0,2
376,Endoderm differentiation WP2853,0.9785112400504152,0.38804412641621944,0.008429484572323964,"['SOX2', 'DUSP4', 'TCEAL2']",0.9991746621801322,0,0,3
377,Prolactin Signaling Pathway WP2037,0.9808927137997739,0.2422360248447205,0.004673263298892868,['RPS6'],0.9991746621801322,0,0,1
378,Chemokine signaling pathway WP3929,0.9833528181985348,0.37065527065527065,0.006222302483647514,"['GRK4', 'PRKCD', 'RASGRP2']",0.9991746621801322,0,0,3
379,Genes related to primary cilium development (based on CRISPR) WP4536,0.9871811685227142,0.30067207014912456,0.003879181346109076,"['CEP120', 'WDR34']",0.9991746621801322,0,0,2
380,Male infertility WP4673,0.9901356797999499,0.20619126589275844,0.002044034833064732,['TEX15'],0.9991746621801322,0,0,1
381,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9901356797999499,0.20619126589275844,0.002044034833064732,['RPS6'],0.9991746621801322,0,0,1
382,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9916389809689541,0.1987892171794091,0.0016690677457044333,['EIF2B5'],0.9991746621801322,0,0,1
383,Nuclear Receptors Meta-Pathway WP2882,0.9945844936733895,0.4305317119694802,0.0023378833502690987,"['PSMC5', 'GSTP1', 'SLC39A11', 'BLVRB', 'PPARA', 'SQSTM1', 'CES2']",0.9991746621801322,0,0,7
384,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9969007649250832,0.1635206321334504,0.0005075758339082695,['PPARGC1B'],0.9991746621801322,0,0,1
385,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9991746621801322,0.1321707787592649,0.00010913058338766914,['SESN3'],0.9991746621801322,0,0,1
